Table 2 Comparison of immune cell characteristics and grade/stage in the epithelial (top panel) and stromal (bottom panel) regions.

From: Profiling the Tumour Immune Microenvironment in Pancreatic Neuroendocrine Neoplasms with Multispectral Imaging Indicates Distinct Subpopulation Characteristics Concordant with WHO 2017 Classification

variables

CD3 low

CD3 high

p value

CD3+/CD4 low

CD3+/CD4 high

p value

CD3+/CD8 low

CD3+/CD8 high

p value

CD20 low

CD20 high

p value

WHO Grade (G1, 2/G3, NEC)

24/2

23/3

0.638

26/0

21/5

0.019

24/2

23/3

0.638

24/2

23/3

0.638

ENETS Stage (I, IIA/IIB-IV)

14/12

15/11

0.780

18/8

11/15

0.051

13/13

16/10

0.402

16/10

13/13

0.402

variables

CD204 low

CD204 high

p value

CD3+/PD-1 low

CD3+/PD-1 high

p value

CD204+/PD-L1 low

CD204+/PD-L1 high

p value

   

WHO Grade (G1, 2/G3, NEC)

26/0

21/5

0.019

26/0

21/5

0.019

26/0

21/5

0.019

   

ENETS Stage (I, IIA/IIB-IV)

17/9

12/14

0.163

19/7

10/16

0.012

19/7

10/16

0.012

   

variables

CD3 low

CD3 high

p value

CD3+/CD4 low

CD3+/CD4 high

p value

CD3+/CD8 low

CD3+/CD8 high

p value

CD20 low

CD20 high

p value

WHO Grade (G1, 2/G3, NEC)

24/2

23/3

0.638

25/1

22/4

0.158

24/2

23/3

0.638

24/2

23/3

0.638

ENETS Stage (I, IIA/IIB-IV)

18/8

11/15

0.051

14/12

15/11

0.78

14/12

15/11

0.78

16/10

13/13

0.402

variables

CD204 low

CD204 high

p value

CD3+/PD-1 low

CD3+/PD-1 high

p value

CD204+/PD-L1 low

CD204+/PD-L1 high

p value

   

WHO Grade (G1, 2/G3, NEC)

24/2

23/3

0.638

25/1

22/4

0.158

25/1

22/4

0.158

   

ENETS Stage (I, IIA/IIB-IV)

16/10

13/13

0.402

18/8

11/15

0.051

15/11

14/12

0.78

   
  1. Pearson’s chi-squared tests were used to compare WHO grade and ENETS stage.